Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension, Primary”

Showing 20 of 0 results

Not applicableUnknownNCT01397110
What this trial is testing

Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects

Who this might be right for
Pulmonary Arterial HypertensionEisenmenger Syndrome
Heidelberg University 50
Not applicableEnded earlyNCT01494896
What this trial is testing

Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching

Who this might be right for
Pulmonary Arterial HypertensionChronic Obstructive Pulmonary Disease
University of Florida 9
Testing effectiveness (Phase 2)Study completedNCT03177603
What this trial is testing

A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Hypertension, Pulmonary
GlaxoSmithKline 23
Not applicableNot Yet RecruitingNCT07374302
What this trial is testing

Riociguat in Triple Therapy for Pulmonary Arterial Hypertension in Real-World Practice

Who this might be right for
Pulmonary Arterial Hypertension
Caio Júlio César dos Santos Fernandes 15
Testing effectiveness (Phase 2)Looking for participantsNCT07318597
What this trial is testing

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Regeneron Pharmaceuticals 99
Not applicableEnded earlyNCT02970851
What this trial is testing

Bosentan in Myocardium Metabolism and Perfusion Measured by 18F-FDG and 82Rb PET/CT on PAH and CTEPH

Who this might be right for
Myocardial DysfunctionEndothelial Dysfunction
University of Lausanne Hospitals 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06176118
What this trial is testing

Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Vanderbilt University Medical Center 12
Not applicableStudy completedNCT00551408
What this trial is testing

Endothelial Progenitor Cells and Pulmonary Idiopathic Arterial Hypertension

Who this might be right for
Pulmonary Idiopathic Arterial Hypertension
Unidad de Investigacion Clinica en Medicina S.C. 20
Large-scale testing (Phase 3)Looking for participantsNCT05179876
What this trial is testing

A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

Who this might be right for
Hypertension, Pulmonary
Actelion 280
Testing effectiveness (Phase 2)Study completedNCT05493371
What this trial is testing

Empagliflozin in Pulmonary Arterial Hypertension

Who this might be right for
Idiopathic Pulmonary Arterial Hypertension
Amsterdam UMC, location VUmc 8
Not applicableNot Yet RecruitingNCT07781709
What this trial is testing

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass-Substudy

Who this might be right for
Pulmonary Arterial Hypertension
University of Pennsylvania 20
Testing effectiveness (Phase 2)Ended earlyNCT00384865
What this trial is testing

Aspirin and Simvastatin in Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
University of Pennsylvania 64
Not applicableNo Longer AvailableNCT01582438
What this trial is testing

An Open Label Access Study For Subjects Who Completed A1481156

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Large-scale testing (Phase 3)Ended earlyNCT01210443
What this trial is testing

Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

Who this might be right for
Hypertension, Pulmonary
Pfizer 2
Not applicableEnrolling By InvitationNCT07558460
What this trial is testing

Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled Trial

Who this might be right for
Idiopathic Pulmonary Arterial Hypertension
Istanbul University - Cerrahpasa 32
Large-scale testing (Phase 3)Study completedNCT01392469
What this trial is testing

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Who this might be right for
Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 21
Not applicableUnknownNCT03045666
What this trial is testing

Impact of Rehabilitation Program on PAH Patients Treated With Macitentan.

Who this might be right for
Pulmonary Arterial Hypertension
Soroka University Medical Center 48
Not applicableStudy completedNCT02909608
What this trial is testing

Actigraphy in Pediatric Pulmonary Hypertension

Who this might be right for
Pediatric Pulmonary Hypertension
University of Colorado, Denver 116
Not applicableStudy completedNCT00367523
What this trial is testing

Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria

Who this might be right for
Secondary Pulmonary Arterial HypertensionSickle Cell DiseasePulmonary Hypertension
National Heart, Lung, and Blood Institute (NHLBI) 308
Not applicableLooking for participantsNCT07176260
What this trial is testing

Exploring Blood Cell Function and Oxidative Stress to Improve Diagnosis and Treatment in Pre-Capillary Pulmonary Hypertension

Who this might be right for
Pre-capillary Pulmonary Hypertension
University Hospital, Strasbourg, France 120
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation